The future of small molecule development is being redefined. But with innovation comes complexity including formulation challenges, developability roadblocks, tight timelines and limited resources. For early-stage pharma companies, the stakes are high; missteps can lead to costly delays, regulatory setbacks, and missed market opportunities. 

Join us in London to learn smart formulation, API-sparing strategies, and how to secure funding for small molecule development. Ideal for emerging pharma startups seeking to accelerate clinical entry and deliver innovative medicines to patients faster. 

Discover strategies with the industry experts as we break down the critical phases of small molecule development, covering formulation strategies, scalable manufacturing solutions, and CMC best practices to accelerate your path to the clinic. Beyond the science, we’ll tackle the drug development business, including aligning with investor expectations and securing funding in a competitive landscape. Gain the insights, tools, and connections you need to de-risk development, optimize your strategy, and fast-track your innovation to market success. Plus, take advantage of exclusive 1:1 office hours with our experts to discuss your molecule challenges. 

Who Should Attend 

Professionals in Preclinical & Formulation Development, CMC, Drug Substance & Product Development, Project Management, Manufacturing & Operations, Supply Chain Management, and pharma consultants seeking a CDMO partner for developing and manufacturing oral solid dosage forms. 

Agenda:

10:00 – 10:45  | Breakfast & Registration

10:45 – 11:00  | Welcome Note
Matthew Streeter, General Manager, Catalent Nottingham

11:00  – 11:30 | Formulating in Early Discovery: Embedding Formulation Considerations into Hit-To-Lead Optimization
David Pearson, Director of Form and Formulation, Sygnature Discovery

11:30  – 12:00 | Formulating with Less API: Application of API Sparing Techniques in Oral Drug Development 
Karl Box, Chief Scientific Officer, Pion Inc

12:00  – 13:00 | Power Lunch

13:00 – 13:30 | Formulating for Success:  Early-Phase Strategies to Avoid Costly Setbacks 
Stephen Tindal, Director, Scientific Advisory, Europe, Catalent

13:30 – 14:00 |Manufacturing Insight: Lessons from 12 Years of the Manufacturing Classification System 
Kendal Pitt, Visiting Professor, University of Strathclyde & Honorary Professor, Leicester School of Pharmacy, De Montfort University 

14:00 – 14:30 | Refresh & Recharge

14:30 – 15:00 | Fast-Tracking Clinical Development: Navigating UK Clinical Trial Regulations to Reduce Risk and Accelerate Timelines 
Karen Chalk, Head of Clinical Project Management & Regulatory Affairs, HMR 
Sally Dowen, Director, Lealto Consulting 

15:00 – 15:30 | Founder's Insight:  Tackling Early Drug Development Challenges with Strategic Partners That Deliver 
Emilia Neuwirt, Co-Founder, CEO EMUNO Therapeutics

15:30 – 16:00 | Fireside Chat: Securing Capital in a Competitive Market - What Early-Stage Pharma Needs to Know
Ronak Savla, Director, Strategic Ventures, Catalent

16:00 - 16:15 | Closing
Matt Ling, Director of Scientific Services, Catalent

16:15 – 17:00 | Networking Cocktail

Registration: Free to attend, please sign up via this link.